Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S, the Danish healthcare giant, has announced a substantial share repurchase program, with plans to buy back B shares worth up to DKK 20 billion over a 12-month period starting from February 6, 2024. As part of this program, the company has already repurchased 2.1 million B shares for DKK 1.85 billion. This buyback initiative is part of Novo Nordisk’s ongoing efforts to return value to shareholders and reflects its strong commitment to financial stewardship.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
